FDA Approves First CRISPR Gene Therapy
Discover how the FDA's landmark approval of Casgevy, the first CRISPR-based treatment, is transforming genetic medicine and offering hope for sickle cell patients.
Discover how the FDA's landmark approval of Casgevy, the first CRISPR-based treatment, is transforming genetic medicine and offering hope for sickle cell patients.